Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis [PDF]
core +1 more source
Comparative cohort study of pregabalin nortriptyline and pregabalin duloxetine in the management of diabetic peripheral neuropathic pain. [PDF]
Dasari PC +8 more
europepmc +1 more source
Duloxetine, an SNRI, Targets pSTAT3 Signaling: <i>In</i>-Silico, RNA-Seq and <i>In</i>-Vitro Evidence for a Pleiotropic Mechanism of Pain Relief. [PDF]
Abdi SAH, Azhar G, Zhang X, Wei JY.
europepmc +1 more source
The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity [PDF]
Bloomfield, MAP +22 more
core +1 more source
Effects of celecoxib combined with duloxetine on chronic pain, depression, and anxiety in patients with knee osteoarthritis. [PDF]
Liu X +5 more
europepmc +1 more source
Comparison of Duloxetine Supplemented With Pregabalin and Amitriptyline Supplemented With Pregabalin for the Treatment of Postherpetic Neuralgia: A Double-Blind, Randomized Crossover Trial. [PDF]
Wang Y +9 more
europepmc +1 more source
Duloxetine: The Next Gold Standard for Treating Depression and Motor Symptoms in Parkinson's Disease? [PDF]
Nogueira GN.
europepmc +1 more source
Inferring drug-disease associations based on known protein complexes [PDF]
core +1 more source
Tonmya (cyclobenzaprine hydrochloride sublingual tablets): first FDA-approved therapy for fibromyalgia in over 15 years. [PDF]
Hujjat SFZ, Zahra SH, Abbas T, Kalam H.
europepmc +1 more source
A longitudinal PET study on changes in brain norepinephrine transporter availability following duloxetine treatment in major depressive disorder. [PDF]
Moriguchi S +10 more
europepmc +1 more source

